Amadeus Capital Partners

Amadeus Capital Partners

United Kingdom; England United Kingdom; Florida United States; California United States; Québec City Quebec Canada; London England United Kingdom; Europe; Northern Europe; Americas; North America; Northwest; Great Lakes
Is it you?
Investor info
Type
Venture Capital
Sweet spot
$10,150,000
Stage focus
  • Seed Round,
  • Early stage VC,
  • Later stage VC,
  • PE Growth/Expansion
Geography focus
Asia, Europe, Israel, South America, United States
Current fund size
$ 75,000,000
Industry focus
Description
Amadeus Capital Partners Limited is a leading United Kingdom global deep-technology venture capital firm headquartered in London (with additional offices in Cambridge, Oxford, San Francisco, and SAGBPo Paulo, Brazil), founded in 1997 by Co-Founders Anne Glover CBE (current CEO; previously at Apax Partners; long-tenured UK VC pioneer and British Private Equity & Venture Capital Association chairwoman) and Dr. Hermann Hauser KBE (Austrian-born British technology pioneer; Cambridge PhD Physics; co-founder of Acorn Computers and instrumental in the spin-out of ARM Holdings aEUR" now one of the world's most important semiconductor IP companies; prolific Cambridge-area serial entrepreneur behind Virata, Net Products, NetChannel, Cambridge Network, Advanced Telecommunication Modules, Solexa, Icera, and many others). The firm backs early- and growth-stage technology companies in Europe and Latin America, focusing on deep-technology themes including artificial intelligence and machine learning, quantum computing, cybersecurity, digital health / medical technology, big data, cloud computing, Internet of Things, semiconductors, and adjacent science-and-technology-led sectors. Amadeus has raised 10+ institutional funds including a GBP110 million early-stage fund backed by British Patient Capital and an a'-80 million joint fund with Austria's APEX Ventures, with aggregate capital raised exceeding USD 1.3 billion invested in 200+ pioneering companies. Managing Partner Alex van Someren leads the Early Stage Funds. Notable portfolio companies and exits include Oxford Nanopore Technologies (LSE: ONT DNA-sequencing unicorn), Graphcore (AI-chip unicorn), CSR plc (LSE: CSR, acquired by Qualcomm), Solexa (acquired by Illumina 2007, foundation of modern DNA-sequencing), Icera (acquired by Nvidia 2011), Entropic Research Laboratory (acquired by Microsoft 1999), VocalIQ (acquired by Apple 2015), Ravelin (acquired by Worldpay 2025), Paragraf, Healx, Oxford Ionics, Secondmind, bit.bio, PhoreMost, XMOS, and ContactEngine (acquired by NICE Systems).
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
X Feed
See other investors focused on
SaaS
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.